We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Byotrol Plc | LSE:BYOT | London | Ordinary Share | GB00B0999995 | ORDS 0.01P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.10 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.05 | 0.15 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 3.97M | -3.06M | -0.0068 | -0.15 | 453.89k |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 0.10 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/4/2024 | 06:00 | UK RNS | AIM Cancellation - Byotrol Plc |
| 29/4/2024 | 13:15 | UK RNS | Byotrol PLC Secondary Trading on Asset Match |
| 23/4/2024 | 17:00 | UK RNS | FTSE Russell Byotrol |
| 22/4/2024 | 15:44 | UK RNS | Byotrol PLC Capital Reorganisation Delay |
| 22/4/2024 | 12:27 | UK RNS | Byotrol PLC Results of General Meeting |
| 15/4/2024 | 10:48 | UK RNS | Byotrol PLC Holding(s) in Company |
| 08/4/2024 | 06:00 | UK RNS | Byotrol PLC Holding(s) in Company |
| 03/4/2024 | 09:59 | ALNC |  TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit |
| 02/4/2024 | 14:27 | UK RNS | Byotrol PLC Director Dealing |
| 28/3/2024 | 07:00 | UK RNS | Byotrol PLC Proposed Cancellation |
Byotrol (BYOT) Share Charts1 Year Byotrol Chart |
|
1 Month Byotrol Chart |
Intraday Byotrol Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 11/12/2024 | 20:49 | BYOTROL-CAN DELIVER AMAZING RESULTS | 12,988 |
| 09/8/2022 | 07:34 | TRADING4GOOD FROM LSE | 2 |
| 24/6/2022 | 07:31 | Byot | - |
| 13/4/2020 | 20:14 | Byotrol (BYOT) One to Watch on Wednesday | 2 |
| 27/2/2016 | 19:04 | Byotrol:::::::::Cleaning Up | 45 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 12/12/2024 08:20 by Byotrol Daily Update Byotrol Plc is listed in the Chemicals & Chem Preps, Nec sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 0.10p.Byotrol currently has 453,890,405 shares in issue. The market capitalisation of Byotrol is £453,890. Byotrol has a price to earnings ratio (PE ratio) of -0.15. This morning BYOT shares opened at - |
Posted at 01/5/2024 18:59 by football BACK TO NEWSByotrol plc admitted to trading on Asset MatchOUR NEWSWEDNESDAY, MAY 01, 2024We are pleased to welcome Byotrol plc to the platform and announce its admission to the Asset Match Private Market.Byotrol plc (BYOT) is a specialist infection prevention and control company, operating globally in the Animal and Human Healthcare sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae. Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, within increasingly stringent regulatory environments.The Company intends run a quarterly auction schedule in the Ordinary Shares. Shares were admitted to trading at 0.11 pence per share (the last traded price on AIM).HTtps://assetma |
Posted at 25/4/2024 19:16 by sikhthetech The problems have also been 1gw and his mates inability to understand the company, sector and markets.This was his post on TLY, stating that the share price has fallen since July 2023, which he suggested was material selling by institutions, making it sound plausible. However, I posted the evidence that he is completely wrong.. Look at the 7 votes up for 1gw's misleading posts. It didn't even appear in top posts. Multiple ids!! 1gw21 Apr '24 - 10:39 - 21190 of 21193 Moderate | Ban 0 7 0 <...> "Yes there have been some holdings notices showing other major holders increasing, but it looks like there has been material net selling by the major holders listed in the annual report (as of late July) doesn't it? This is consistent with the share price trend since then, isn't it?" My post providing evidence that 1gw is completely wrong, again sikhthetech21 Apr '24 - 18:44 - 21191 of 21193 Edit 0 4 0 1gw, <...> "Yes there have been some holdings notices showing other major holders increasing, but it looks like there has been material net selling by the major holders listed in the annual report (as of late July) doesn't it? This is consistent with the share price trend since then, isn't it?" No, look at the evidence. I said in Sept that there was no evidence of significant selling by institutions (note, significant and plural institutions). The evidence backs that assertion and you have been proven wrong. AR of 27th July, total holdings > 3% 91,754,158 AGM result: unanimously voted for majority of the resolutions 91,552,076 91m in July and similar voted in Sept. There is NO evidence of institutions selling between July and H1. <...> |
Posted at 15/4/2024 20:00 by mudbath Medimark ScientificFor a consideration of £4.5million Byotrol envisaged:- "Immediately provides Byotrol with greater scale than could be achieved through current rates of organic growth. Medimark is profitable and cash generative and fits extremely well with Byotrol's existing products and technology. · Expected to be materially earnings enhancing in first year from acquisition. The combination of the two businesses will greatly accelerate Byotrol's growth profile whilst significantly reducing the execution risk from purely organic expansion. · Highly complementary acquisition, offering extensive sales, marketing and distribution expertise in Byotrol's core markets. Specific complementarity with Byotrol's Professional and Petcare businesses with significant synergies expected over time, including:· Enhanced distribution of Byotrol technologies to Medimark customers, in the UK and overseas, boosting economies of scale, distribution and market segment expertise · Highly experienced, well-connected and resilient sales team and sales support · Introduction of stronger disinfectant technologies to Byotrol portfolio including a proprietary sporicidal formulation · Doubles Byotrol workforce, creating immediate critical mass with cost synergies available from bringing Medimark technical work in house. · Medimark is on track to deliver EBITDA of £500k for the full year to March 2019, which will trigger the first earn-out payment · Executive management staying with the combined business for the earnout and beyond, with incentives closely aligned with Byotrol shareholders. Executive management locked-in from share sales for three years from completion." Following the Acquisition, it is expected that Byotrol will have cash balances in excess of £2.5m, providing more than sufficient resource to drive growth of the combined businesses." Add in a subsequent pandemic and one has to seriously question the competence of Byotrol's managegement when current reality includes a possible delisting and yet another upcoming cash call. |
Posted at 07/4/2024 15:36 by loafofbread Less than 2 years ago they thought 3.25p was a decent price.35 times more than our current share price Todays price is as artificial as you could get. The second relates to the Convertible Bond. The Group issued a Convertible Bond for GBP1m in July 2022 to new and existing investors in the Company, including Board directors. The Loan Notes have a term of five years, are senior in ranking, unsecured and convertible at investors' option into ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 3.25 pence per Ordinary Share, representing a 30% premium to the mid-price of the Company's share price at close of business on 26 July 2022. The Loan Notes carry a coupon of 9% per annum, payable quarterly in arrears. Based on the issue size of GBP1,000,000, the Loan Notes would, if converted, represent approximately 30,769,230 Ordinary Shares, amounting to 6.8% of the current issued share capital of the Company. However, as the average Byotrol share price since the issue of the Convertible Bond has been below the 3.25p conversion price, these are currently classed as non-dilutive and do not feature in the Denominator calculation above. |
Posted at 05/4/2024 14:11 by mudbath Well as the Byotrol share price has been manoeuvred downwards to almost zero I would suggest that there is considerable value to be had through investing at around 0.09p; for little has changed since the share price was ten or more times higher.I would not be surprised to see corporate action prior to the General Meeting. |
Posted at 04/4/2024 13:10 by kumbuka mudbath12 Jan '13 - 10:06 - 7 of 12704 0 0 0 The covering analyst at Finncap,Dr.Keith Redpath,suggests that Byotrol might lose £700k over the full year to Mar 31st 2013.This would indicate a loss of just £23k for the current six months. If correct,the losses for the past 3 six monthly trading periods would read:- March 2012= £1377k Sept 2012= £677k March 2013= £23k An impressive trend then,which if maintained, could see BYOT report profits of over £500k for the six months to Sept 2013;although Byotrol house brokers are forecasting a more modest 300k profit for the full year. Reading between the lines,BYOT are looking at a surge in orders.Why else would they be seeking to put in place a significant invoice discounting facility with their bankers. With an IDF in place,Finncap predict BYOT could turn cash flow neutral within the current trading period,possibly then precluding the need for a further large cash raising exercise After several disappointing years,Byotrol seems to be coming good at quite a pace,and imo this pace could quicken Finncap have in place an initial share price target of 15 pence. The share price chart currently looks strong and it could be that such a level is soon tested. A very interesting investment opportunity. |
Posted at 02/4/2024 13:34 by tradertrev Personally I think management have shown that they are no longer interested in the wider shareholder base and have fallen into the classic smallcap trap of thinking that the current shareholders are somehow to blame for the appalling share price performance, not realising that it is the ex-shareholders who sold the shares that brought the share price down.It is the long-suffering long term holders who have been punished by the lack of any good news from the company, which is now being compounded my management turning their backs on us. If management of an AIM company is not on our side, then in my view there is no basis to hold the shares, so I dumped nearly all my shares last week at 0.1p except for one tiny account where the proceeds wouldn't have paid the contract fee! Fortunately this was never a big holding for me - I think I bought them back in the Noughties! I wish continuing shareholders better fortune going forward. TT |
Posted at 31/3/2024 19:55 by sikhthetech Warnings about marketing/supply chains and the time for a placing was when it was obvious covid was a pandemic.sikhthetech - 26 Oct 2021 - 18:57:43 - 8940 of 10283 1gw, You're clueless, as usual...read the company newsflow... The time for a placing was last year, March-April, in the middle of the 1st lockdown. Byot knew in March sales rose significantly. March, there was a lockdown and by April it was clear there was a pandemic. So I think a placing March-April would have been well received by IIs and PIs, as was the case with many other companies. The share price end of March was around 5p, so around current share price <...> April 2020: "We continue to experience exceptional demand for our technologies across all our markets due to the covid19 pandemic. We expect this to continue for at least the first quarter of FY2021 and likely beyond, and are now expecting to benefit significantly from a secular shift towards the heightened importance of infection prevention, cleanliness and hygiene, whether personal, institutional or environmental." It isn't hindsight either as you wrongly claim, on 17th March 2020, I posted the following. What part of the highlighted sentence don't you understand? sikhthetech - 17 Mar 2020 - 20:12:36 - 4993 of 8940 The problem isn't it's effectiveness, it's their supply chain, their marketing. <...> |
Posted at 20/3/2024 12:41 by kumbuka BYOTmudbath 12 Jan '13 - 10:06 - 7 of 12570 0 0 0 The covering analyst at Finncap,Dr.Keith Redpath,suggests that Byotrol might lose £700k over the full year to Mar 31st 2013.This would indicate a loss of just £23k for the current six months. If correct,the losses for the past 3 six monthly trading periods would read:- March 2012= £1377k Sept 2012= £677k March 2013= £23k An impressive trend then,which if maintained, could see BYOT report profits of over £500k for the six months to Sept 2013;although Byotrol house brokers are forecasting a more modest 300k profit for the full year. Reading between the lines,BYOT are looking at a surge in orders.Why else would they be seeking to put in place a significant invoice discounting facility with their bankers. With an IDF in place,Finncap predict BYOT could turn cash flow neutral within the current trading period,possibly then precluding the need for a further large cash raising exercise After several disappointing years,Byotrol seems to be coming good at quite a pace,and imo this pace could quicken Finncap have in place an initial share price target of 15 pence. The share price chart currently looks strong and it could be that such a level is soon tested. A very interesting investment opportunity. |
Posted at 20/3/2024 11:58 by mudbath I wonder what it is "coming down the tracks" sufficient to derail the BYOT share price to such an extent.My leaning is towards the announcement strategic review; although a futher BoD resignation, a delisting or a placing could be alternative scenarios. Byotrol carries way too many staff whose purpose is unclear. We should soon find out. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
